# Independent Product review — Spec v1

Composition: local-fallback Product review required by refine-idea. D-011 waives configured model diversity and effort verification. Reviewer received only frozen Spec v1, settled-state snapshot and assigned coverage, not CEO findings.

Full validated envelope: ../runs/20261101T204330Z-f-auditor/objects/envelopes/dbf18901738266a31f7e433271da5c8c838d83f6befd0c972c19438f16eba20d.json

## Findings

ID: R-004 (PRODUCT-001)
Reviewer: Product
Severity: medium
Artifact / section: spec.md / FR-004, FR-007 and invocation journey
Evidence: FR-007 names functional-improvement/ without anchoring it independently of invocation directory.
Why it matters: Different repositories could receive competing backlog files instead of one shared source of truth.
Smallest proposed change: Require one consistently resolved, documented backlog destination for the same configuration. Test invocations from two different repositories.
Human decision required: no
Resolution: accepted; pending Spec v2 synthesis

ID: R-005 (PRODUCT-002)
Reviewer: Product
Severity: medium
Artifact / section: spec.md / completion and regression lifecycle
Evidence: FR-010 requires proof of post-fix recurrence, but the permitted human-maintained completed status does not specify fix evidence or how to surface insufficient evidence.
Why it matters: Status-only completion can make subsequent observations unclassifiable without an actionable report.
Smallest proposed change: Document contributor completion/fix evidence and explicitly report unresolved recurrence classification, without creating unsupported regressions or changing completed status.
Human decision required: no
Resolution: accepted; pending Spec v2 synthesis

ID: R-006 (PRODUCT-003)
Reviewer: Product
Severity: high
Artifact / section: spec.md / FR-005 and measurable outcomes
Evidence: SC-001 verifies selection; SC-002 checks only fields of reported findings, so no-findings on positive examples can pass.
Why it matters: The central contextual-analysis behavior has no acceptance gate.
Smallest proposed change: Add annotated positive and negative cases and verify expected problem detection and exclusions, not exact generated wording.
Human decision required: no
Resolution: accepted; canonical duplicate of R-002, preserving independent Product attribution

## Coverage

All COV-001–COV-009 items reviewed with evidence, including no-finding items. Local structural, semantic, protected-hash and coverage checks passed. Native verified-model/effort envelope contract remains waived, not passed.
